Patents Assigned to 20Bloc, Inc.
  • Patent number: 12698320
    Abstract: Provided herein are modified hemoglobin (Hb) comprising at least two subunits of a Hb intramolecularly crosslinked with a compound of formula (I), or salt, stereoisomer, or deuterated form thereof, wherein X, R1, and R2 are defined herein. The modified Hb can further comprise residues functionalized with reactive groups. Also provided herein are multimerized hemoglobin (Hb) compositions comprising a reaction product of: the modified Hb comprising a residue functionalized with one or more first reactive groups for click reaction and a reactant molecule comprising second reactive groups complementary to the first reactive group for the click reaction.
    Type: Grant
    Filed: May 15, 2025
    Date of Patent: August 4, 2026
    Assignee: 20BLOC, INC.
    Inventors: Alex Lepak, David Rozzell, Sky Ferrara, Kai Lu, Martin Michael Dcona, Nitin Pawar, Erik Goebel
  • Patent number: 12570600
    Abstract: Provided herein are compounds of formula (I), or salt, stereoisomer, or deuterated form thereof, wherein X, R1, and R2 are defined herein. Also provided herein are conjugated compositions comprising reacted units of a molecule (e.g., a protein) and a compound of formula (I), or salt, stereoisomer, or deuterated form thereof.
    Type: Grant
    Filed: January 24, 2025
    Date of Patent: March 10, 2026
    Assignee: 20Bloc, Inc.
    Inventors: Alexander Lepak, Skylar J. Ferrara, Kai Lu, David Rozzell, Erik S. Goebel